HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $52,917,000 | +19.8% | 2,002,195 | -11.4% | 0.24% | +11.2% |
Q4 2018 | $44,154,000 | -8.0% | 2,259,727 | -7.8% | 0.22% | +12.0% |
Q3 2018 | $48,004,000 | -11.6% | 2,451,701 | -25.3% | 0.19% | -20.0% |
Q2 2018 | $54,325,000 | +2.2% | 3,280,467 | -9.9% | 0.24% | +8.6% |
Q1 2018 | $53,130,000 | 0.0% | 3,639,173 | 0.0% | 0.22% | 0.0% |
Q4 2017 | $53,130,000 | +5.9% | 3,639,173 | -8.0% | 0.22% | +0.5% |
Q3 2017 | $50,173,000 | +185.3% | 3,956,981 | +231.6% | 0.22% | +161.9% |
Q2 2017 | $17,586,000 | 0.0% | 1,193,420 | 0.0% | 0.08% | 0.0% |
Q1 2017 | $17,586,000 | -4.7% | 1,193,420 | +4.6% | 0.08% | -16.0% |
Q4 2016 | $18,452,000 | -50.4% | 1,140,538 | -44.4% | 0.10% | -52.2% |
Q3 2016 | $37,169,000 | +97.3% | 2,050,199 | +278.1% | 0.21% | +53.7% |
Q2 2015 | $18,838,000 | -31.2% | 542,278 | -48.6% | 0.14% | -32.0% |
Q1 2015 | $27,375,000 | – | 1,054,141 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Scale Management, LLC | 1,710,451 | $37,065,000 | 56.74% |
Broadfin Capital, LLC | 8,131,310 | $176,205,000 | 10.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,684,801 | $253,210,000 | 10.26% |
ATERNALIS CAPITAL LLC | 410,000 | $8,885,000 | 5.84% |
JW Asset Management, LLC | 673,075 | $14,586,000 | 5.44% |
NEXTHERA CAPITAL LP | 144,000 | $3,120,000 | 4.43% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 739,485 | $16,025,000 | 2.77% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,519,955 | $54,607,000 | 2.66% |
Ratan Capital Management LP | 500,000 | $10,835,000 | 2.39% |
TIGER MANAGEMENT L.L.C. | 823,577 | $17,847,000 | 2.30% |